The City of Compton Pays Tribute to Dr. Vinson Eugene Allen

MMJ Submits FDA Investigational New Drug Application for Cannabis-Derived Drug

Reinforcing Its Commitment to Security and Client Trust

A fellowship-trained ankle and foot surgeon and expert in lower-limb salvage, Srinivas will provide a comprehensive range of podiatric services and support the practice's treatment of complex lower extremity conditions.

- This is Dermata's first allowed U.S. patent application for DMT310, using its Spongilla technology to topically treat acne -

- Dermata recently completed enrollment in its DMT310 Phase 3 STAR-1 study for the treatment of acne and expects to announce topline results in March 2025 -

- Over 30 million acne patients seek treatment in the U.S. each year, with topical products being first-line therapy -

~ Supply Chain Now Fully Secure for PF614-MPAR ~

54% of patients experience more than 2.5 years of durable hematocrit (Hct) control (<45%), decreased phlebotomy use, long-term tolerability, and improvements in patient-reported outcomes in patients with polycythemia vera

Close-Up Televisions Jim Masters discusses the many ways and levels of healing people in a new video series with Dr. Christy Soto-Johnson

This post was written and published as a collaboration between the in-house editorial team at Benzinga and Tonix Pharmaceuticals Holding Corp. with financial support from Tonix. The two organizations work to ensure that any and all information contained within is true and accurate as of the date hereof to the best of their knowledge and research. This content is for informational purposes only and not intended to be investing advice.

The study is one of five clinical efforts - three IIT proof-of-concept studies and two Phase 2 studies - of crofelemer for the rare disease indications of SBS-IF and/or microvillus inclusion disease (MVID), an ultrarare congenital diarrheal disorder, in the US, EU, and/or Middle East/North Africa (MENA) regions; availability of IIT proof-of-concept results potentially in Q2 2025

Crofelemer, Jaguar's novel plant-based prescription drug, has been granted Orphan Drug Designation by the FDA and the European Medicines Agency for both SBS-IF and MVID

Kourtney Chuman, RN and Nicolette Kohler, RN were Travel Nurses, Inc.'s 49th and 50th DAISY Award honorees.

Vituity and Sayvant have solidified an enterprise-wide agreement to elevate the clinician experience and streamline care delivery, setting a new standard for innovation in acute care.

Patients at the West Palm Beach health clinic get lower costs and better outcomes on EBOO and other safe and effective IV therapies

Exploding with momentum: CBDL shatters records with 622% revenue growth in five months, propelling to a 1,405% year-to-date increase-a game-changer in the CBD industry.

UDS Health and Relentless Health jointly announce the launch of their collaboration to bring simple, accurate PFAS testing to fire departments across the US.

Powered by Aptevo's proprietary ADAPTIR-FLEX^®platform, antibody innovation targeting difficult-to-treat cancers

~ $10 Million Commitment from Specialty Drug Manufacturer to Support Commercialization Efforts ~

Liom, formerly known as Spiden, a pioneer in non-invasive biomarker monitoring aiming to develop the first non-invasive glucose monitoring wearable, is thrilled to announce significant technological milestones and a successful kick-off of its Series A.

MobilityWorks has opened a new location in the Raleigh community to provide those with limited mobility access to wheelchair accessible vehicles, services and resources.

HITRUST r2 Certification validates Jorie AI is committed to strong cybersecurity and protecting sensitive data.

GJK Facility Services Director George Stamas Delivers Closing Speech

- STAR-1 topline results expected in March 2025 -

- Over 30 million acne patients seek treatment in the U.S. each year -

- Phase 2b for DMT310 achieved statistically significant results for all primary endpoints -

Focused Ultrasound Therapy for tremors is now available for patients with Dr. Taghva in Orange County

Diarrhea is one of the most common reasons for veterinary visits for dogs and the second most common reason for visits to the veterinary emergency room, yet there are currently no FDA-approved drugs to treat general diarrhea in dogs

New trials to evaluate IGC-AD1's potential impact on amyloid plaque, tau tangles, and cognitive decline in Alzheimer's disease

Expanded research positions IGC-AD1 as a potential treatment targeting the underlying disease pathology of Alzheimer's

VELOXA® Very Low Oxalate Teas SCIENTIFICALLY TESTED

Bringing yet another clinical breakthrough to the 2024 RSNA Annual Meeting, AGFA HealthCare is excited to announce a new partnership with CARPL.ai - the world's largest radiology AI marketplace.

Renowned expert Dr. Rubinstein to train practitioners on new BOTOX® technique for smoother neck contours in New York.

Ankle & Foot Centers of America's Columbus office, led by Dr. Jennifer Monaco, partners with the Job Training Division of Columbus, GA, to offer hands-on internships for aspiring healthcare professionals. This unique program provides students with real-world experience in podiatric medicine, fostering skills and inspiring future careers in healthcare.

Self Regional Healthcare aims to upgrade its PACS, enhance diagnostic imaging capabilities, and strengthen its financial position while optimizing staff workflows. By adopting AGFA HealthCare's Enterprise Imaging Cloud, they are poised to successfully achieve these objectives.

Renowned Facial Plastic Surgeon Dr. Rubinstein has been selected to train professionals on FDA-approved BOTOX® Cosmetic for neck rejuvenation in New Jersey.